ARQT
Arcutis Biotherapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$22.75
-0.16 ▼ -0.70%
🌙 3월 13일 6:50 PM ET (한국 3/14 07:50)
$22.54
-0.21 ▼ -0.92%
| Index | RUT | P/E | - | EPS (ttm) | -0.14 | Insider Own | 11.85% | Shs Outstand | 0.12B | Perf Week | -5.21% |
| Market Cap | 2.82B | Forward P/E | 18.84 | EPS next Y | 256.75% | Insider Trans | -3.62% | Shs Float | 0.11B | Perf Month | -14.44% |
| Enterprise Value | 2.71B | PEG | - | EPS next Q | -0.05 | Inst Own | 97.29% | Short Float | 13.99% | Perf Quarter | -23.58% |
| Income | -0.02B | P/S | 7.5 | EPS this Y | 360.37% | Inst Trans | 3.91% | Short Ratio | 9.97 | Perf Half Y | 28.6% |
| Sales | 0.38B | P/B | 14.81 | EPS next 5Y | - | ROA | -4.13% | Short Interest | 15.29M | Perf YTD | -21.66% |
| Book/sh | 1.54 | P/C | 12.75 | EPS past 3/5Y | 71.8% 49.34% | ROE | -9.3% | 52W High | -28.39% ($31.77) | Perf Year | 53.61% |
| Cash/sh | 1.78 | P/FCF | - | Sales past 3/5Y | 367.27% - | ROIC | -5.33% | 52W Low | 91.82% ($11.86) | Perf 3Y | 93.95% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 88.8% | Gross Margin | 90.24% | Volatility(W/M) | 4.34% 5.62% | Perf 5Y | -30.11% |
| Dividend TTM | - | EV/Sales | 7.22 | Sales Y/Y TTM | 91.34% | Oper. Margin | -3.25% | ATR (14) | 1.35 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.99 | EPS Q/Q | 248.38% | Profit Margin | -4.29% | RSI (14) | 35.88 | Recom | 1.25 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.17 | Sales Q/Q | 81.48% | SMA20 | -10.41% ($25.39) | Beta | 1.78 | Target Price | $34.75 |
| Payout | - | Debt/Eq | 0.6 | Earnings | 2000000 | SMA50 | -13.67% ($26.35) | Rel Volume | 0.58 | Prev Close | $22.91 |
| Employees | 354 | LT Debt/Eq | 0.6 | EPS/Sales Surpr. | 40.69% 14.55% | SMA200 | 6.99% ($21.26) | Avg Volume(3M) | 1.53M | Price | $22.75 |
| IPO | 2020/1/31 | Option/Short | Yes/Yes | Trades | 11777 | Volume | 890,479 | Change | -0.7% |
뉴스 로딩 중...